CCBE1: Difference between revisions

Jump to navigation Jump to search
 
m (Added a reference for the molecular etiology.)
Line 5: Line 5:
== Function ==
== Function ==


This gene is thought to function in [[extracellular matrix]] remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary [[carcinoma]]s, suggesting its role as a [[tumor suppressor gene|tumor suppressor]].<ref name="entrez"/>
CCBE1 is a regulator of the development and growth of the [[lymphatic system]]. CCBE1 is necessary for the proteolytic activation of [[VEGF-C]] by [[ADAMTS3]]<ref name=pmid24552833>{{Cite journal| doi = 10.1161/CIRCULATIONAHA.113.002779| volume = 129| issue = 19| pages = 1962-71| last1 = Jeltsch| first1 = Michael| last2 = Jha| first2 = Sawan Kumar| last3 = Tvorogov| first3 = Denis| last4 = Anisimov| first4 = Andrey| last5 = Leppänen| first5 = Veli-Matti| last6 = Holopainen| first6 = Tanja| last7 = Kivelä| first7 = Riikka| last8 = Ortega| first8 = Sagrario| last9 = Kärpanen| first9 = Terhi| last10 = Alitalo| first10 = Kari| title = CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3-Mediated Vascular Endothelial Growth Factor-C Activation| journal = Circulation| date = 2014| url = http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002779| pmid = 24552833}}</ref>, which is the main growth factor for the lymphatic system <ref name=pmid9162011>{{Cite journal| doi = 10.1126/science.276.5317.1423| pmid = 9162011 | volume = 276| issue = 5317| pages = 1423-25| last1 = Jeltsch| first1 = Michael| last2 = Kaipainen| first2 = Arja| last3 = Joukov| first3 = Vladimir| last4 = Meng| first4 = Xiaojuan| last5 = Lakso| first5 = Merja| last6 = Rauvala| first6 = Heikki| last7 = Swartz| first7 = Melody| last8 = Fukumura| first8 = Dai| last9 = Jain| first9 = Rakesh K.| last10 = Alitalo| first10 = Kari| title = Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice| journal = Science| date = 1997| url = http://dx.doi.org/10.1126/science.276.5317.1423}}</ref>.


== Clinical significance ==
== Clinical significance ==


Mutation in the CCBE1 gene may be associated with [[Hennekam syndrome]], a generalized lymphatic dysplasia in humans .<ref name="pmid19935664">{{cite journal |vauthors=Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF, Offerhaus GJ, Prescott TE, Schroor EJ, Verheij JB, Witte M, Zwijnenburg PJ, Vikkula M, Schulte-Merker S, Hennekam RC | title = Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans | journal = Nat. Genet. | volume = 41 | issue = 12 | pages = 1272–4 |date=December 2009 | pmid = 19935664 | doi = 10.1038/ng.484 | url =  }}</ref>
[[Hennekam syndrome]] type I (a generalized lymphatic dysplasia in humans) is associated with mutations in the CCBE1 gene<ref name="pmid19935664">{{cite journal |vauthors=Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF, Offerhaus GJ, Prescott TE, Schroor EJ, Verheij JB, Witte M, Zwijnenburg PJ, Vikkula M, Schulte-Merker S, Hennekam RC | title = Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans | journal = Nat. Genet. | volume = 41 | issue = 12 | pages = 1272–4 |date=December 2009 | pmid = 19935664 | doi = 10.1038/ng.484 | url =  }}</ref>, and the molecular etiology of the disease has been elucidated<ref name=pmid24552833></ref>.
 


==References==
==References==

Revision as of 11:10, 28 December 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Collagen and calcium-binding EGF domain-containing protein 1 is a protein that in humans is encoded by the CCBE1 gene.[1][2]

Function

CCBE1 is a regulator of the development and growth of the lymphatic system. CCBE1 is necessary for the proteolytic activation of VEGF-C by ADAMTS3[3], which is the main growth factor for the lymphatic system [4].

Clinical significance

Hennekam syndrome type I (a generalized lymphatic dysplasia in humans) is associated with mutations in the CCBE1 gene[5], and the molecular etiology of the disease has been elucidated[3].


References

  1. "Entrez Gene: collagen and calcium binding EGF domains 1".
  2. Nagase T, Kikuno R, Ohara O (December 2001). "Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins". DNA Res. 8 (6): 319–27. doi:10.1093/dnares/8.6.319. PMID 11853319.
  3. 3.0 3.1 Jeltsch, Michael; Jha, Sawan Kumar; Tvorogov, Denis; Anisimov, Andrey; Leppänen, Veli-Matti; Holopainen, Tanja; Kivelä, Riikka; Ortega, Sagrario; Kärpanen, Terhi; Alitalo, Kari (2014). "CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3-Mediated Vascular Endothelial Growth Factor-C Activation". Circulation. 129 (19): 1962–71. doi:10.1161/CIRCULATIONAHA.113.002779. PMID 24552833.
  4. Jeltsch, Michael; Kaipainen, Arja; Joukov, Vladimir; Meng, Xiaojuan; Lakso, Merja; Rauvala, Heikki; Swartz, Melody; Fukumura, Dai; Jain, Rakesh K.; Alitalo, Kari (1997). "Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice". Science. 276 (5317): 1423–25. doi:10.1126/science.276.5317.1423. PMID 9162011.
  5. Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF, Offerhaus GJ, Prescott TE, Schroor EJ, Verheij JB, Witte M, Zwijnenburg PJ, Vikkula M, Schulte-Merker S, Hennekam RC (December 2009). "Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans". Nat. Genet. 41 (12): 1272–4. doi:10.1038/ng.484. PMID 19935664.

External links

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.